Financhill
Back

Regeneron Pharmaceuticals Stock Predictions

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Buy
59

REGN
Regeneron Pharmaceuticals

Last Price:
900.55
Seasonality Move:
10.55%

7 Day Trial

ALL ACCESS PASS

$ 7

America's Final Republican President

Click here to see his 2024 election prediction.

Regeneron Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 33.3% based on the past 33 years of stock performance.
  • Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
  • Is Regeneron Pharmaceuticals Stock Undervalued?
    The current Regeneron Pharmaceuticals [REGN] share price is $900.16. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Regeneron Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 33.3% based on the past 33 years of stock performance.

Regeneron Pharmaceuticals Stock Rating

Buy
59
Regeneron Pharmaceuticals (REGN) is a Buy

Is Regeneron Pharmaceuticals overpriced?

  • Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%

Regeneron Pharmaceuticals Stock Price History

Is REGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com

52-Week Data

52-Week High:
998.33
52-Week Low:
684.81

Prediction Charts

Market Cap:
98.8B
Price in USD:
900.16
Volume:
333.21K
Beta:
0.95

Technical Analysis

SMA50:
951.90
SMA100:
922.40
SMA200:
860.19
52-Wk Change:
12.42%

Stock Predictions

  • Is Regeneron Pharmaceuticals stock public?
    Yes, Regeneron Pharmaceuticals is a publicly traded company.
  • What is the Regeneron Pharmaceuticals stock quote today?
    The Regeneron Pharmaceuticals stock price is 900.16 USD today.
  • How to buy Regeneron Pharmaceuticals stock online?
    You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-3 955.00 950.95 961.68 950.43
Apr-4 962.20 937.02 962.20 935.36
Apr-5 939.31 941.97 949.83 934.87
Apr-8 939.16 938.49 942.99 935.51
Apr-9 941.39 943.48 949.20 938.00
Apr-10 935.02 936.20 937.87 923.44
Apr-11 928.58 920.16 930.64 907.33
Apr-12 911.55 904.69 912.22 898.26
Apr-15 915.37 898.38 921.12 895.09
Apr-16 897.22 894.14 901.07 890.43
Apr-17 903.88 901.48 911.64 899.90
Apr-18 901.26 893.50 908.81 891.67
Apr-19 913.97 896.84 920.73 891.46
Apr-22 904.54 900.16 908.67 897.45

Regeneron Pharmaceuticals Earnings

Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regeneron Pharmaceuticals Forecast Revenue Growth

Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.01 per share, an increase this year of $2.51 per share, and an increase next year of $2.21 per share.

* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.